(Q36458127)

14 August 2017

1 reference

title

Atherogenesis in rheumatology (English)

1 reference

14 August 2017

4

G R Hughes

1 reference

14 August 2017

2

J J P Kastelein

1 reference

14 August 2017

S I van Leuven

1

1 reference

14 August 2017

D P D'Cruz

series ordinal

3

1 reference

14 August 2017

E S Stroes

series ordinal

5

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

15

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

117-121

1 reference

The bimodal mortality pattern of systemic lupus erythematosus

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

The cardiovascular burden of lupus: a complex challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

The oxidative modification hypothesis of atherogenesis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Mannose-binding lectin recognizes peptidoglycan via the N-acetyl glucosamine moiety, and inhibits ligand-induced proinflammatory effect and promotes chemokine production by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Mannose binding lectin: genetics and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Surrogate markers for atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Update on vascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Accelerated atheroma and anti-beta2-glycoprotein I antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2273RR

10.1191/0961203306LU2273RR

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference